NM_000899.5:c.15+16673C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000899.5(KITLG):​c.15+16673C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.659 in 152,128 control chromosomes in the GnomAD database, including 36,740 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.66 ( 36740 hom., cov: 33)

Consequence

KITLG
NM_000899.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.108

Publications

4 publications found
Variant links:
Genes affected
KITLG (HGNC:6343): (KIT ligand) This gene encodes the ligand of the tyrosine-kinase receptor encoded by the KIT locus. This ligand is a pleiotropic factor that acts in utero in germ cell and neural cell development, and hematopoiesis, all believed to reflect a role in cell migration. In adults, it functions pleiotropically, while mostly noted for its continued requirement in hematopoiesis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
KITLG Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 69
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hyperpigmentation with or without hypopigmentation, familial progressive
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial progressive hyper- and hypopigmentation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial progressive hyperpigmentation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Waardenburg syndrome type 2
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • Waardenburg syndrome, IIa 2F
    Inheritance: Unknown, AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.795 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KITLGNM_000899.5 linkc.15+16673C>T intron_variant Intron 1 of 9 ENST00000644744.1 NP_000890.1 P21583-1A0A024RBC0
KITLGNM_003994.6 linkc.15+16673C>T intron_variant Intron 1 of 8 NP_003985.2 P21583-2A0A024RBF5
LOC124902979XR_007063398.1 linkn.1185+617C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KITLGENST00000644744.1 linkc.15+16673C>T intron_variant Intron 1 of 9 NM_000899.5 ENSP00000495951.1 P21583-1

Frequencies

GnomAD3 genomes
AF:
0.659
AC:
100189
AN:
152010
Hom.:
36736
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.303
Gnomad AMI
AF:
0.752
Gnomad AMR
AF:
0.782
Gnomad ASJ
AF:
0.858
Gnomad EAS
AF:
0.722
Gnomad SAS
AF:
0.803
Gnomad FIN
AF:
0.784
Gnomad MID
AF:
0.861
Gnomad NFE
AF:
0.800
Gnomad OTH
AF:
0.700
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.659
AC:
100213
AN:
152128
Hom.:
36740
Cov.:
33
AF XY:
0.664
AC XY:
49391
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.302
AC:
12524
AN:
41464
American (AMR)
AF:
0.782
AC:
11949
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.858
AC:
2976
AN:
3470
East Asian (EAS)
AF:
0.722
AC:
3738
AN:
5174
South Asian (SAS)
AF:
0.805
AC:
3887
AN:
4828
European-Finnish (FIN)
AF:
0.784
AC:
8298
AN:
10582
Middle Eastern (MID)
AF:
0.864
AC:
254
AN:
294
European-Non Finnish (NFE)
AF:
0.800
AC:
54424
AN:
68016
Other (OTH)
AF:
0.700
AC:
1479
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1425
2849
4274
5698
7123
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.705
Hom.:
5291
Bravo
AF:
0.640
Asia WGS
AF:
0.726
AC:
2525
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.8
DANN
Benign
0.41
PhyloP100
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7953414; hg19: chr12-88957368; API